Melanin-concentrating hormone (MCH); melanin-concentrating hormone receptor 1 (MCHR1) BriefCommunication Pages: 619 - 619
IL-17; IL-27; osteopontin (OPN; secreted phosphoprotein 1; Spp1); type I interferon receptor (IFNAR1) BriefCommunication Pages: 620 - 620
Single immunoglobulin and toll-interleukin 1 receptor (TIR) domain (Sigirr; Tir8) BriefCommunication Pages: 621 - 621
Nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1; NPM); F-box and WD-40 domain protein 7 (Fbxw7) BriefCommunication Pages: 622 - 622
Ras/methyl ethyl ketone/extracellular signal–regulated kinase signaling cascade (Ras/MEK/ERK signaling cascade); checkpoint kinase 1 (Chk1) BriefCommunication Pages: 624 - 624
Prostate apoptosis response protein 4 (Pawr; Par-4); Ras; protein kinase B (PKB; Akt); protein kinase C-ζ (PKC-ζ); NF-κB BriefCommunication Pages: 625 - 625
Tumor necrosis factor receptor superfamily, member 10b (TNFRSF10B; DR5; TRAIL-R2); tumor necrosis factor (ligand) superfamily, member 10 (TNFSF10; TRAIL; APO2L) BriefCommunication Pages: 629 - 629
Mycobacterium tuberculosis strain H37Rv membrane-associated serine protease (Rv3671c) BriefCommunication Pages: 630 - 630
Phospholipase A2 (PLA2); human group X secreted PLA2 (hGX sPLA2); mouse group X secreted PLA2 (mGX sPLA2) BriefCommunication Pages: 631 - 631
γ-secretase; anterior pharynx defective 1 homologB (Aph1B); neuregulin 1 (Nrg1) BriefCommunication Pages: 634 - 634
Identification of drug targets using analysis of common side effects BriefCommunication Pages: 636 - 636
Incorporating a pNO2-modified phenylalanine amino acid into an antigen to produce a more immunogenic protein for vaccine development BriefCommunication Pages: 637 - 637